Angiotech Pharmaceuticals Inc. has appointed John R. Barr CEO, the firm said Oct. 9. Barr takes over from Thomas Bailey, who stepped down from his president and CEO role on Oct. 8, but will continue to serve on the company's board of directors.
Barr most recently served as executive VP and president, global surgical at Bausch & Lomb Inc., prior to its acquisition...